Stock STMN STRAUMANN HOLDING AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials Straumann Holding AG

Equities

STMN

CH1175448666

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange
Other stock markets
 11:31:30 2024-04-26 am EDT 		5-day change 1st Jan Change
138.1 CHF +3.41% Intraday chart for Straumann Holding AG +3.76% +1.84%
Apr. 12 Dental Equipment Company Straumann Names New Chair MT
Mar. 26 Stocks Blink Green Amid Modest Growth Forecast for Switzerland MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 15,048 16,394 30,811 16,832 21,608 22,019 - -
Enterprise Value (EV) 1 15,028 16,278 30,435 16,625 21,436 21,757 21,466 21,075
P/E ratio 49.4 x 180 x 78 x 38.8 x 88.1 x 46 x 38.1 x 32.3 x
Yield 0.61% 0.56% 0.35% 0.76% 0.63% 0.67% 0.79% 0.88%
Capitalization / Revenue 9.43 x 11.5 x 15.2 x 7.25 x 8.96 x 8.51 x 7.64 x 6.86 x
EV / Revenue 9.41 x 11.4 x 15.1 x 7.16 x 8.89 x 8.4 x 7.45 x 6.57 x
EV / EBITDA 31.2 x 40.1 x 46.6 x 23.3 x 29.5 x 28 x 24.1 x 20.8 x
EV / FCF 65.3 x 55.2 x 69.3 x 75.7 x 68.2 x 58.6 x 46.3 x 37.1 x
FCF Yield 1.53% 1.81% 1.44% 1.32% 1.47% 1.71% 2.16% 2.7%
Price to Book 11.1 x 13.6 x 20.6 x 9.09 x 11.8 x 10.1 x 8.44 x 7.05 x
Nbr of stocks (in thousands) 158,334 158,933 159,066 159,399 159,355 159,443 - -
Reference price 2 95.04 103.2 193.7 105.6 135.6 138.1 138.1 138.1
Announcement Date 2/18/20 2/16/21 2/15/22 2/21/23 2/21/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,596 1,426 2,022 2,321 2,412 2,589 2,881 3,209
EBITDA 1 481 406 652.4 712.1 727.2 777.3 890 1,014
EBIT 1 387 156.5 553.3 602.6 606.4 634 735.2 844.1
Operating Margin 24.25% 10.98% 27.37% 25.96% 25.14% 24.49% 25.52% 26.31%
Earnings before Tax (EBT) 1 365.5 113.9 477.4 498.4 345.6 585 705 803.5
Net income 1 306.5 91.28 396.1 434.8 246.1 480.9 580.8 678.6
Net margin 19.2% 6.4% 19.59% 18.73% 10.2% 18.57% 20.16% 21.15%
EPS 2 1.925 0.5730 2.482 2.720 1.540 3.005 3.626 4.271
Free Cash Flow 1 230 295 439.3 219.7 314.5 371.3 463.7 568.8
FCF margin 14.41% 20.69% 21.73% 9.47% 13.04% 14.34% 16.1% 17.73%
FCF Conversion (EBITDA) 47.82% 72.66% 67.34% 30.86% 43.25% 47.77% 52.1% 56.08%
FCF Conversion (Net income) 75.05% 323.17% 110.92% 50.54% 127.82% 77.22% 79.83% 83.81%
Dividend per Share 2 0.5750 0.5750 0.6750 0.8000 0.8500 0.9197 1.086 1.211
Announcement Date 2/18/20 2/16/21 2/15/22 2/21/23 2/21/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q3 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2
Net sales 1 816.2 605.1 820.8 985.5 496.3 540.1 1,036 588.9 589.4 1,178 550.5 592.8 1,142 596 621.3 1,217 570.6 624.3 1,195 631.8 650.5 1,302 620 668 1,350
EBITDA 257.8 123.9 282 332.6 - - 319.8 - - 381.7 - - 330.4 - - 375.7 - - 351.5 - - - - - -
EBIT 207.7 100.2 230.3 284 - - 269.4 - - 329.1 - - 273.5 - - 316.7 - - 289.7 - - 337.6 - - 322.8
Operating Margin 25.45% 16.56% 28.06% 28.81% - - 25.99% - - 27.93% - - 23.94% - - 26.03% - - 24.24% - - 25.93% - - 23.91%
Earnings before Tax (EBT) 192.3 -97.96 - - - - - - - - - - - - - - - - 90.13 - - - - - -
Net income 160 -93.46 184.7 172.8 - - 223.2 - - 265.4 - - 169.4 - - 205.8 - - 40.3 - - - - - -
Net margin 19.6% -15.45% 22.51% 17.54% - - 21.54% - - 22.52% - - 14.83% - - 16.91% - - 3.37% - - - - - -
EPS 1.004 -0.5890 1.162 1.084 - - 1.398 - - 1.670 - - 1.050 - - 1.290 - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - - - - - - - - - - - - -
Announcement Date 2/18/20 8/13/20 2/16/21 8/11/21 10/28/21 2/15/22 2/15/22 5/16/22 8/16/22 8/16/22 11/2/22 2/21/23 2/21/23 5/15/23 8/15/23 8/15/23 10/31/23 2/21/24 2/21/24 - - - - - -
1CHF in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 20.2 116 376 208 172 262 553 944
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 230 295 439 220 315 371 464 569
ROE (net income / shareholders' equity) 24% 7.7% 28.8% 24.9% 22.9% 24% 24.2% 23.8%
ROA (Net income/ Total Assets) 13.6% 3.9% 14.3% 13.6% 13% 13.4% 14.8% 15.5%
Assets 1 2,253 2,341 2,770 3,197 1,893 3,592 3,925 4,384
Book Value Per Share 2 8.590 7.580 9.400 11.60 11.50 13.60 16.40 19.60
Cash Flow per Share 2 2.380 2.360 3.510 2.600 3.160 4.080 4.630 5.450
Capex 1 150 82 121 195 189 203 205 217
Capex / Sales 9.38% 5.75% 5.98% 8.42% 7.85% 7.85% 7.12% 6.77%
Announcement Date 2/18/20 2/16/21 2/15/22 2/21/23 2/21/24 - - -
1CHF in Million2CHF
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Straumann Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
138.1 CHF
Average target price
141.6 CHF
Spread / Average Target
+2.50%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

1st Jan change Capi.
STRAUMANN HOLDING AG Stock Straumann Holding AG
+1.84% 23.32B
COCHLEAR LIMITED Stock Cochlear Limited
+7.40% 13.63B
DEMANT A/S Stock Demant A/S
+10.34% 9.89B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD. Stock Eyebright Medical Technology (Beijing) Co., Ltd.
-17.75% 2B
EMBLA MEDICAL HF. Stock Embla Medical hf.
+6.38% 1.79B
ANGELALIGN TECHNOLOGY INC. Stock Angelalign Technology Inc.
+41.47% 1.64B
MODERN DENTAL GROUP LIMITED Stock Modern Dental Group Limited
+13.26% 600M
ANGEL ROBOTICS CO., LTD. Stock Angel Robotics Co., Ltd.
0.00% 475M
DELCATH SYSTEMS, INC. Stock Delcath Systems, Inc.
+27.40% 134M
INTEGRUM AB Stock Integrum AB
+21.80% 86.89M
Medical Prosthetics
  1. Stock Market
  2. Equities
  3. STMN Stock
  4. Financials Straumann Holding AG